[SARS-CoV-2 infection in pregnant women: Tunisian series of 11 cases]

[SARS-CoV-2 感染孕妇:突尼斯 11 例病例系列]

阅读:1

Abstract

INTRODUCTION: in pregnant women, the symptoms of COVID-19 join those of the general population in most cases. However, like any population at risk, more serious symptoms can appear such as pneumonia or ARDS. In our study, we propose to define the clinical, biological and therapeutic characteristics as well as the management of a series of pregnant women suffering from COVID-19. METHODS: this is a prospective and descriptive study which brought together 11 pregnant patients affected by the Coronavirus SARS-CoV-2 in the gynecology-obstetrics department of Mohamed Tlatli hospital, Nabeul, Tunisia between 12(th) September and 11(th) November 2020. RESULTS: the average age is 31.18 years. Six patients were followed for a chronic disease. Gestational diabetes was the most common comorbidity. Contact with a suspected or confirmed case of COVID-19 was identified in 6 patients. The average incubation period of the virus was 5.89 days. Average term of pregnancy was 33.36 weeks with amenorrhea. The preferred route of delivery was cesarean section. The most frequently reported symptoms were fever in all patients, dry cough, dyspnea and headache in nine patients. Two patients were subsequently treated in medical intensive care for a picture of acute respiratory distress syndrome (ARDS). Both patients were put on high flow nasal oxygen therapy: Optiflow without the need for mechanical ventilation. In the remaining 9 cases, symptomatic treatment and antibiotic therapy were sufficient and the patients returned to their homes. We have had no mother-to-child transmission and no death. Breastfeeding does not seem to influence this transmission. CONCLUSION: the most frequently reported symptoms were fever in all patients, followed by dry cough, dyspnea and headache. There was no mother-to-child transmission, nor transmission during breastfeeding. In general, symptomatic and antibiotic treatment was sufficient. We are currently facing the second wave of the virus. Our efforts will have to be based on a better clinical knowledge of this new coronavirus and adapt a management function accordingly.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。